Cargando…

Adjuvant bleomycin, vincristine and cisplatin (BOP) for high-risk stage I non-seminomatous germ cell tumours: a prospective trial (MRC TE17)

Adjuvant BEP (bleomycin, etoposide, cisplatin) is effective treatment for high-risk clinical stage I (HRCS1) non-seminomatous germ cell tumours (NSGCT), but the known toxicities of etoposide, and the expansion of the HR group to any patient with vascular invasion (50% of patients), led the Medical R...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dearnaley, D P, Fossa, S D, Kaye, S B, Cullen, M H, Harland, S J, Sokal, M P J, Graham, J D, Roberts, J T, Mead, G M, Williams, M V, Cook, P A, Stenning, S P
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2005
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361823/ https://www.ncbi.nlm.nih.gov/pubmed/15928672 http://dx.doi.org/10.1038/sj.bjc.6602624

Ejemplares similares

Prognostic factors in patients progressing after cisplatin-based chemotherapy for malignant non-seminomatous germ cell tumours
por: Fosså, S D, et al.
Publicado: (1999)

Long-term outcomes with intensive induction chemotherapy (carboplatin, bleomycin, vincristine and cisplatin/bleomycin, etoposide and cisplatin) and standard bleomycin, etoposide and cisplatin in poor prognosis germ cell tumours: A randomised phase II trial (ISRCTN53643604)
por: Cafferty, Fay H., et al.
Publicado: (2020)

Bleomycin, vincristine, cisplatin/bleomycin, etoposide, cisplatin chemotherapy: an alternating, dose intense regimen producing promising results in untreated patients with intermediate or poor prognosis malignant germ-cell tumours
por: Anthoney, D A, et al.
Publicado: (2004)

A Medical Research Council randomized trial of single agent carboplatin versus etoposide and cisplatin for advanced metastatic seminoma
por: Horwich, A, et al.
Publicado: (2000)

The changing role of surgery in metastatic non-seminomatous germ cell tumour.
por: Cassidy, J., et al.
Publicado: (1992)

Improving the outcome of salvage treatment for non-seminomatous germ cell tumours (NSGCT)
por: Bono, J S de, et al.
Publicado: (2000)

Surgery in metastatic non-seminomatous germ cell tumours.
por: Tobias, J. S.
Publicado: (1992)

Results of treatment of non seminomatous germ cell tumours; 122 consecutive cases in the West of Scotland, 1981-1985.
por: Graham, J., et al.
Publicado: (1988)

Intensive induction chemotherapy with C-BOP/BEP for intermediate- and poor-risk metastatic germ cell tumours (EORTC trial 30948)
por: Fosså, S D, et al.
Publicado: (2005)

Prognostic factors in clinical stage I non-seminomatous germ-cell tumours of the testis.
por: Raghavan, D., et al.
Publicado: (1982)

Frequency of serum tumour marker monitoring in patients with non-seminomatous germ cell tumours.
por: Seckl, M. J., et al.
Publicado: (1990)

Management preferences in stage I non-seminomatous germ cell tumours of the testis: an investigation among patients, controls and oncologists.
por: Cullen, M. H., et al.
Publicado: (1996)

Cisplatin, vincristine and ifosphamide combination chemotherapy of metastatic seminoma: results of EORTC trial 30874. EORTC GU Group.
por: Fosså, S. D., et al.
Publicado: (1995)

The epidemiology of non-seminomatous germ cell tumours in the west of Scotland 1975-89.
por: Harding, M., et al.
Publicado: (1995)

Distinct Proteomic Profile of Spermatozoa from Men with Seminomatous and Non-Seminomatous Testicular Germ Cell Tumors
por: Panner Selvam, Manesh Kumar, et al.
Publicado: (2020)

Glycan composition of serum alpha-fetoprotein in patients with hepatocellular carcinoma and non-seminomatous germ cell tumour
por: Johnson, P J, et al.
Publicado: (1999)

Long-term follow-up of residual masses after chemotherapy in patients with non-seminomatous germ cell tumours
por: Napier, M P, et al.
Publicado: (2000)

Post-chemotherapy surgery in advanced non-seminomatous germ-cell testicular tumours: the significance of histology with particular reference to differentiated (mature) teratoma.
por: Tait, D., et al.
Publicado: (1984)

Alternating dose-dense chemotherapy in patients with high volume disseminated non-seminomatous germ cell tumours
por: Fizazi, K, et al.
Publicado: (2002)

The role of radiotherapy after chemotherapy in the management of persistent para-aortic nodal disease in non-seminomatous germ cell tumours.
por: Read, G., et al.
Publicado: (1986)

A phase II trial of TIP (paclitaxel, ifosfamide and cisplatin) given as second-line (post-BEP) salvage chemotherapy for patients with metastatic germ cell cancer: a medical research council trial
por: Mead, G M, et al.
Publicado: (2005)

The management of low-stage non-seminomatous germ cell tumors
por: Lim, Louise, et al.
Publicado: (2012)

A Randomised Phase 2 Trial of Intensive Induction Chemotherapy (CBOP/BEP) and Standard BEP in Poor-prognosis Germ Cell Tumours (MRC TE23, CRUK 05/014, ISRCTN 53643604)
por: Huddart, Robert A., et al.
Publicado: (2015)

Hard bop
por: Medina Castro, Iván
Publicado: (2022)

Non-Seminomatous Germ Cell Tumor Presenting with Superior Vena Cava Syndrome
por: Soriano, Paolo K., et al.
Publicado: (2017)

MRC2020: improvements to Ximdisp and the MRC image-processing programs
por: Short, J. M., et al.
Publicado: (2023)

Inflammation stops at Bop
por: Maxmen, Amy
Publicado: (2009)

Non-Seminomatous Germ Cell Tumor Metastasis to the Jaw: An Imaging Case Report
por: Siverino, Rita Olivia, et al.
Publicado: (2016)

A Scottish national audit of current patterns of management for patients with testicular non-seminomatous germ-cell tumours. The Scottish Radiological Society and the Scottish Committee of the Royal College of Radiologists.
por: Howard, G. C., et al.
Publicado: (1995)

Non-seminomatous germ cell tumor with bone metastasis only at diagnosis: A rare clinical presentation
por: Biebighauser, K.C., et al.
Publicado: (2017)

Second cancer risk and mortality in men treated with radiotherapy for stage I seminoma
por: Horwich, A, et al.
Publicado: (2014)

Phase I-II study of carboplatin vincristine methotrexate and bleomycin (COMB) in carcinoma of the cervix.
por: Rustin, G. J., et al.
Publicado: (1988)

Two Cases of Cerebral Sinus Venous Thrombosis Following Chemotherapy for Non-Seminomatous Germ Cell Tumor
por: Papet, C., et al.
Publicado: (2011)

Urethral metastasis from non-seminomatous germ cell tumor: a case report
por: Agarwal, Vijay, et al.
Publicado: (2011)

Bone marrow metastasis in a patient with non‐seminomatous testicular germ cell tumor
por: Ueda, Takashi, et al.
Publicado: (2022)

Comparing gingivitis diagnoses by bleeding on probing (BOP) exclusively versus BOP combined with visual signs using large electronic dental records
por: Patel, Jay S., et al.
Publicado: (2023)

Surveillance or etoposide-containing combination chemotherapy for stage I non-seminomatous germ cell tumours of the testis (NSGCTT)
por: Colls, B. M.
Publicado: (1994)

Chemoimmunotherapy with bleomycin, vincristine, lomustine, dacarbazine (BOLD) plus interferon alpha for metastatic melanoma: a multicentre phase II study.
por: Punt, C. J., et al.
Publicado: (1997)

Sequential resection of residual abdominal and thoracic masses after chemotherapy for metastatic non-seminomatous germ cell tumours.
por: Gerl, A., et al.
Publicado: (1994)

Compliance with follow-up of patients treated for non-seminomatous testicular cancer.
por: Young, B. J., et al.
Publicado: (1991)

Cannot write session to /tmp/vufind_sessions/sess_88av0vb9hibv34170sdl6q172n